Synopsys EPS (Diluted) decreased by 86.1% to $0.34 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 82.0%, from $1.89 to $0.34. Over 4 years (FY 2021 to FY 2025), EPS (Diluted) shows an upward trend with a 13.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate stronger profitability even when accounting for potential share dilution.
Calculated by dividing net income by the weighted-average number of common shares outstanding, assuming the conversion o...
Used by all public companies to provide a realistic view of earnings per share for investors.
eps_diluted| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.24 | $1.27 | $1.27 | $1.99 | $1.89 | $1.43 | $0.98 | $1.75 | $1.76 | $2.17 | $2.24 | $2.89 | $1.88 | $2.61 | $7.13 | $1.89 | $2.21 | $1.50 | $2.44 | $0.34 |
| QoQ Change | — | +2.4% | -0.0% | +56.7% | -5.0% | -24.3% | -31.5% | +78.6% | +0.6% | +23.3% | +3.2% | +29.0% | -34.9% | +38.8% | +173.2% | -73.5% | +16.9% | -32.1% | +62.7% | -86.1% |
| YoY Change | — | — | — | — | +52.4% | +12.6% | -22.8% | -12.1% | -6.9% | +51.7% | +128.6% | +65.1% | +6.8% | +20.3% | +218.3% | -34.6% | +17.6% | -42.5% | -65.8% | -82.0% |